European Journal of Medicinal Chemistry p. 455 - 464 (2019)
Update date:2022-07-29
Topics:
Winters, Maria
DuHadaway, James B.
Pham, Khoa N.
Lewis-Ballester, Ariel
Badir, Shorouk
Wai, Jenny
Sheikh, Eesha
Yeh, Syun-Ru
Prendergast, George C.
Muller, Alexander J.
Malachowski, William P.
Tryptophan (Trp) catabolizing enzymes play an important and complex role in the development of cancer. Significant evidence implicates them in a range of inflammatory and immunosuppressive activities. Whereas inhibitors of indoleamine 2,3-dioxygenase-1 (IDO1) have been reported and analyzed in the clinic, fewer inhibitors have been described for tryptophan dioxygenase (TDO) and indoleamine 2,3-dioxygenase-2 (IDO2) which also have been implicated more recently in cancer, inflammation and immune control. Consequently the development of dual or pan inhibitors of these Trp catabolizing enzymes may represent a therapeutically important area of research. This is the first report to describe the development of dual and pan inhibitors of IDO1, TDO and IDO2.
View MoreHaiNan Periwinkle Pharmaceutical Co.,Ltd.
website:http://www.cchpharm.com/en/index.html
Contact:020-82208978
Address:Gongye road,Wuzhishan city,HaiNan province
Qingdao XinYongAn Chemicals Co., Ltd
Contact:+86-532-81107967
Address:Chengyang dual-port industrial park by the sea,Qingdao
Tianjin Te-An Chemtech Co., Ltd.(expird)
Contact:+86-22-65378638
Address:A5-8, No.80 Haiyun Street, TEDA
Kunshan Yalong Trading Co,.Ltd
Contact:86-512-57621185
Address:805-807 Room Hongqiao Mansion ,1088 West Qianjin Road, Kunshan, Jiangsu,China
Chengdu Aslee Biopharmaceuticals, Inc
Contact:18608018419
Address:Chengdu Aslee Biopharmaceuticals, Inc
Doi:10.1021/ol900779v
(2009)Doi:10.1016/0008-6215(87)85004-8
(1987)Doi:10.1016/j.jorganchem.2008.09.059
(2009)Doi:10.1002/jhet.5570390104
(1898)Doi:10.1021/acs.orglett.9b01192
(2019)Doi:10.1016/S0040-4039(00)96366-4
(1987)